Healthtech Growth Investors & VC Firms
1213 firms in this list, with a median first check of $1.1M. 281 of them lead rounds. Generated from verified public data and updated continuously.
Whiz Partners Inc.
TokyoSeed–Late Stage$500K – $5M
6 people
EDB Investments
SingaporeSeed–Late Stage$12M – $400M
11 people
Next Orbit Ventures Fund-I
MumbaiSeed–Late Stage
8 people
Powerhouse Ventures
Fortitude ValleySeed–Late Stage
8 people
Citta Capital
Palo AltoPre-Seed–Growth
2 people
BOV Capital
ColomboSeed–Growth$100K
4 people
PBM Capital
CharlottesvilleSeed–Late Stage
6 people
SBCVC
TortolaSeed–Late Stage
6 people
Affinity Equity Partners
SingaporeGrowth–Late Stage$250M – $1B
5 people
Blue Highway Capital
PhiladelphiaGrowth$3M – $8M
5 people
BoldMind Capital Partners
The HagueGrowth
8 people
Caribbean Opportunities Fund
GeorgetownGrowth$1M – $5M
5 people
Globalive Capital
TorontoPre-Seed–Growth
8 people
HBM Partners
ZugPre-Seed–Late Stage$5M – $50M
5 people
Health2047 Capital Partners LLC
Menlo ParkSeed–Late Stage
5 people
Mubadala Capital
LondonSeries A–Late Stage$1M – $50M
5 people
Verdane
StockholmSeries B–Growth$21.6M – $162M
11 people
TRICAPITAL
Scottish BordersSeed–Growth$315K – $2.5M
2 people
Split Rock Partners
Eden PrairieSeed–Late Stage$2M – $40M
4 people
The Riverside Company
ClevelandGrowth
7 people
Asia Business Builders
Growth
6 people
Happiness Capital
Hong KongSeed–Growth
6 people
Minds Capital
St. PetersburgGrowth
3 people
WAMEX Private Equity
Mexico CityGrowth–Late Stage
5 people
Related lists
Growth Investors & VC Firms (4757)Healthtech Investors & VC Firms (3208)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Healthtech Investors & VC Firms in United States (1616)Growth Investors & VC Firms in United States (1502)Growth Investors & VC Firms in Global (1414)Healthtech Pre-Seed Investors & VC Firms (1328)Healthtech Series B Investors & VC Firms (1216)Enterprise Software Growth Investors & VC Firms (1186)
Data sourced from public filings and firms' own websites — see our methodology.


















































